Login Give a Gift
Login Give a Gift
In this section

Manufacturer Product Alerts

Visit this page for an up-to-date listing of manufacturer withdrawal or recall of therapy products. 

AnnouncedManufacturerMedication/Product Recall or ReplacementPatient Guidance
January 26, 2024 – Voluntary RecallTakedaVoluntary Recall of VonVendi 650 ius due to misprint of expiration dates on vial and packaging. Read the full Takeda announcement.Patients are instructed to direct questions to their physicians or their local Hemophilia Treatment Center.
August 28, 2023 – Voluntary RecallTakedaBaxject II Reconstitution Device – Voluntary replacement of device packed in certain lot numbers of Recombinate and Rixubis. View announcement.Patients are instructed to direct questions to their physician or their local Hemophilia Treatment Center.
AnnouncedManufacturerMedication/Product Recall or ReplacementPatient Guidance
January 20, 2021CSL BehringMononine - Voluntary Product Recall NotificationPatients are instructed to direct questions regarding the recall, risks, or possible adverse effects from this medication, to their physician or their local Hemophilia Treatment Center.
July 19, 2019 – Voluntary RecallBAYERKogenate® FS – View FDA WebsitePatients are instructed to direct questions regarding the recall, risks, or possible adverse effects from this medication, to their physician or their local Hemophilia Treatment Center. Patients may also contact the FDA at 1.800.332.1088 or visit the FDA's website for further information.